Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air for 6.6 Hours at Rest in Healthy Young Adults.

NCT06943989 is registered in ClinicalTrials.gov with Environmental Protection Agency (EPA) as lead sponsor.

NCT NCT06943989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06943989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air for 6.6 Hours at Rest in Healthy Young Adults.
Lead sponsor
Environmental Protection Agency (EPA)
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 5, 2024
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

experimental lung inflammation, lung inflammation